Skip to content

Clinical trials

Phase 1/2 Hematologic Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 1/2 Country / region: United Kingdom Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20071
20101
20111
20141
20192
20201
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
AGC Biologics S.p.A.1
BeOne Medicines1
Bellicum Pharmaceuticals1
CellCentric Ltd.1
Chroma Therapeutics1
Clavis Pharma1
Faron Pharmaceuticals Ltd1
ImCheck Therapeutics, an Ipsen company1
Imperial College London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms13
Leukemia4
Leukemia, Myeloid, Acute4
Myelodysplastic Syndromes3
Neoplasms3
Lymphoma, Non-Hodgkin2
Multiple Myeloma2
Anemia1
Anemia, Aplastic1
Anemia, Diamond-Blackfan1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.